Pavlos Msaouel, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Commentary European Urology led by Daniel Shapiro on how the observed adjuvant immunotherapy trial result discrepancies in kidney cancer can be explained by simple trial design principles.
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power
Authors: Daniel Shapiro, Pavlos Msaouel.”
